Northwire Canada EditionWednesday, July 15, 2026
Northwire
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%
Earnings

KITS Eyecare Reports Preliminary Third Quarter 2025 Results

KITS · Price

Executive Summary

  • Q3 2025 total revenue rose 25.1% YoY to approximately $52.4 M, indicating strong top‑line growth.
  • Adjusted EBITDA improved to roughly 5.2% of revenue, reflecting better profitability margins.
  • New customers increased 27.6% YoY to about 99,000, and cash balances remain solid at $19.7 M.

Key Details

  • Revenue: $52.4 million (≈ +25.1% YoY).
  • Adjusted EBITDA: ~5.2% of revenue (up from prior period).
  • Customer Growth: 99,000 new customers in Q3 2025 (+27.6% YoY).
  • Cash Position: $19.7 million as of quarter‑end.
  • Management Comment: CEO Roger Hardy highlighted “strong results while navigating border changes and postal strikes” and praised team focus on the mission of making eyecare easy for everyone.
  • Forward Outlook: Full Q3 2025 results to be released in early November 2025; conference call details forthcoming.

Notable Quotes

“KITS delivered strong results while navigating multiple complexities including border changes and postal strikes. I'm proud of how our team stayed focused on our mission of making eyecare easy for everyone.” – Roger Hardy, Co‑Founder & CEO, KITS

Read the original news release →

More from KITS EYECARE LTD.